Russell T Walton

Title: Russell T Walton: Innovator in CRISPR Technology

Introduction

Russell T Walton is a prominent inventor based in Waban, MA (US). He has made significant contributions to the field of genetic engineering, particularly through his work with CRISPR technology. With a total of 2 patents, Walton is recognized for his innovative approaches to genome editing.

Latest Patents

Walton's latest patents include groundbreaking advancements in CRISPR technology. One of his notable inventions is titled "Unconstrained genome targeting with near-PAMless engineered CRISPR-Cas9 variants." This patent focuses on Cas9 (SpCas9) variants that possess relaxed PAM requirements, enabling high-resolution editing for various applications. Another significant patent is "CRISPR-Cas enzymes with enhanced on-target activity," which details engineered versions of Cas9 (SpCas9) and its variants that exhibit improved on-target editing capabilities.

Career Highlights

Walton is affiliated with The General Hospital Corporation, where he continues to push the boundaries of genetic research. His work has been instrumental in advancing the capabilities of CRISPR technology, making it more accessible and effective for various applications in medicine and biotechnology.

Collaborations

Walton collaborates with fellow researcher Benjamin Kleinstiver, contributing to the development of innovative CRISPR solutions. Their partnership has led to significant advancements in the field, enhancing the potential of genome editing technologies.

Conclusion

Russell T Walton is a key figure in the realm of CRISPR technology, with a focus on enhancing genome editing capabilities. His contributions through patents and collaborations continue to shape the future of genetic engineering.